To analyze whether the localization of CD163+ and CD68+ macrophages had a correlation to clinical characteristics, the distribution of CD163+ and CD68+ macrophages in tumor and tumor-free tissues was evaluated separately (Figure 2). This evidence concerns the gene CD163 and neoplasm.